McRae Robert Curtis 4
4 · PALISADE BIO, INC. · Filed Apr 5, 2023
Insider Transaction Report
Form 4
McRae Robert Curtis
Chief Operating Officer
Transactions
- Exercise/Conversion
Restricted Stock Units
2023-04-03−655→ 1,963 total→ Common Stock (655 underlying) - Exercise/Conversion
Common Stock, par value $0.01
2023-04-03+655→ 895 total - Tax Payment
Common Stock, par value $0.01
2023-04-03$2.00/sh−270$540→ 625 total
Footnotes (3)
- [F1]Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date.
- [F2]Represents shares withheld by Issuer to satisfy tax withholding requirements on vesting of restricted stock units.
- [F3]This restricted stock unit was granted on January 3, 2023, and 655 restricted stock units subject to the award vested on April 3, 2023, and approximately 654 restricted stock units are scheduled to vest on each of July 3, 2023, October 3, 2023, and January 3, 2023, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting.